| human | Q5 |
| P496 | ORCID iD | 0000-0002-1962-9322 |
| P7293 | PLWABN ID | 9810599071905606 |
| P214 | VIAF ID | 315222398 |
| P7859 | WorldCat Identities ID (superseded) | viaf-315222398 |
| P735 | given name | Celine | Q18338336 |
| Celine | Q18338336 | ||
| P106 | occupation | researcher | Q1650915 |
| P21 | sex or gender | female | Q6581072 |
| Q35871567 | 19p13.1 is a triple-negative-specific breast cancer susceptibility locus |
| Q37169873 | 9q31.2-rs865686 as a susceptibility locus for estrogen receptor-positive breast cancer: evidence from the Breast Cancer Association Consortium |
| Q40597341 | A Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci |
| Q35755874 | A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor-negative breast cancer |
| Q35957063 | A comprehensive evaluation of interaction between genetic variants and use of menopausal hormone therapy on mammographic density |
| Q44971724 | A comprehensive examination of CYP19 variation and breast density |
| Q33844619 | A comprehensive examination of CYP19 variation and risk of breast cancer using two haplotype-tagging approaches |
| Q37619303 | A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46,450 cases and 42,461 controls from the breast cancer association consortium |
| Q35089479 | A locus on 19p13 modifies risk of breast cancer in BRCA1 mutation carriers and is associated with hormone receptor-negative breast cancer in the general population |
| Q36435849 | A meta-analysis of genome-wide association studies of breast cancer identifies two novel susceptibility loci at 6q14 and 20q11. |
| Q92711687 | A network analysis to identify mediators of germline-driven differences in breast cancer prognosis |
| Q30662344 | A new statistic for identifying batch effects in high-throughput genomic data that uses guided principal component analysis |
| Q36790591 | A novel automated mammographic density measure and breast cancer risk |
| Q35082982 | A polygenic risk score for breast cancer in women receiving tamoxifen or raloxifene on NSABP P-1 and P-2. |
| Q57305942 | A transcriptome-wide association study of 229,000 women identifies new candidate susceptibility genes for breast cancer |
| Q61948755 | Abstract 3266: Expression quantitative trait locus analysis of triple negative breast cancer |
| Q64075852 | Accuracy of self-reported cancer treatment data in young breast cancer survivors |
| Q36581161 | Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study |
| Q61670285 | Adult daughters' reports of breast cancer risk reduction and early detection advice received from their mothers: an exploratory study |
| Q39437211 | Age- and Tumor Subtype-Specific Breast Cancer Risk Estimates for CHEK2*1100delC Carriers |
| Q61670374 | Age-Related Lobular Involution and Risk of Breast Cancer |
| Q46667230 | Age-specific trends in mammographic density: the Minnesota Breast Cancer Family Study |
| Q40045112 | Alcohol consumption and breast tumor gene expression |
| Q46568926 | Alcohol intake in adolescence and mammographic density |
| Q40362782 | Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development |
| Q37251054 | An automated approach for estimation of breast density |
| Q35681656 | Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis |
| Q57268421 | Anthropometric Characteristics, Physical Activity, and Risk of Non-Hodgkin's Lymphoma Subtypes and B-Cell Chronic Lymphocytic Leukemia: A Prospective Study |
| Q30429037 | Aromatase immunoreactivity is increased in mammographically dense regions of the breast |
| Q34613673 | Assessing interactions between the associations of common genetic susceptibility variants, reproductive history and body mass index with breast cancer risk in the breast cancer association consortium: a combined case-control study |
| Q37117079 | Assessment of the accuracy of the Gail model in women with atypical hyperplasia |
| Q35218520 | Assessment of variation in immunosuppressive pathway genes reveals TGFBR2 to be associated with prognosis of estrogen receptor-negative breast cancer after chemotherapy |
| Q45979098 | Association analysis identifies 65 new breast cancer risk loci. |
| Q47134558 | Association between mammographic breast density and histologic features of benign breast disease |
| Q28212542 | Association of aspirin and nonaspirin nonsteroidal anti-inflammatory drugs with cancer incidence and mortality |
| Q28196753 | Association of aspirin and other non-steroidal anti-inflammatory drug use with incidence of non-Hodgkin lymphoma |
| Q37684672 | Association of breast cancer risk with genetic variants showing differential allelic expression: Identification of a novel breast cancer susceptibility locus at 4q21. |
| Q61670369 | Association of diabetes with mammographic breast density and breast cancer in the Minnesota breast cancer family study |
| Q73501369 | Association of diet and mammographic breast density in the Minnesota breast cancer family cohort |
| Q92431571 | Association of elevated serumfree light chains with chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis |
| Q34809698 | Association of genetic variation in genes implicated in the beta-catenin destruction complex with risk of breast cancer |
| Q114182713 | Association of germline genetic variants with breast cancer-specific survival in patient subgroups defined by clinic-pathological variables related to tumor biology and type of systemic treatment |
| Q37132557 | Association of mammographic density with the pathology of subsequent breast cancer among postmenopausal women |
| Q48551885 | Association of mammographically defined percent breast density with epidemiologic risk factors for breast cancer (United States). |
| Q52576610 | Association of polygenic risk score with the risk of chronic lymphocytic leukemia and monoclonal B-cell lymphocytosis. |
| Q35022847 | Associations of breast cancer risk factors with tumor subtypes: a pooled analysis from the Breast Cancer Association Consortium studies |
| Q57056093 | Associations of obesity and circulating insulin and glucose with breast cancer risk: a Mendelian randomization analysis |
| Q34199209 | Automated Percentage of Breast Density Measurements for Full-field Digital Mammography Applications |
| Q64914458 | Automated and Clinical Breast Imaging Reporting and Data System Density Measures Predict Risk for Screen-Detected and Interval Cancers: A Case-Control Study. |
| Q90984178 | Automated volumetric breast density measures: differential change between breasts in women with and without breast cancer |
| Q36002291 | Awareness of breast density and its impact on breast cancer detection and risk |
| Q35580614 | Background parenchymal uptake during molecular breast imaging and associated clinical factors |
| Q36836825 | Background parenchymal uptake on molecular breast imaging as a breast cancer risk factor: a case-control study |
| Q92091490 | Behavioral and psychological impact of returning breast density results to Latinas: study protocol for a randomized clinical trial |
| Q28262894 | Benign breast disease and the risk of breast cancer |
| Q37021220 | Benign breast disease, mammographic breast density, and the risk of breast cancer |
| Q46115524 | Body mass index and breast cancer survival: a Mendelian randomization analysis |
| Q64079292 | Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype |
| Q36090967 | Breast Density and Benign Breast Disease: Risk Assessment to Identify Women at High Risk of Breast Cancer |
| Q46441726 | Breast Density: More Than Meets the Eye. |
| Q34327945 | Breast cancer risk and 6q22.33: combined results from Breast Cancer Association Consortium and Consortium of Investigators on Modifiers of BRCA1/2 |
| Q34131826 | Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use |
| Q42352120 | Breast cancer risk by the extent and type of atypical hyperplasia |
| Q54335820 | Breast cancer risk in women with radial scars in benign breast biopsies. |
| Q35940158 | Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. |
| Q38200713 | Breast density and breast cancer risk: a practical review |
| Q33635885 | Can genes for mammographic density inform cancer aetiology? |
| Q34998459 | Case-control study of increased mammographic breast density response to hormone replacement therapy. |
| Q34380497 | Centrosome-related genes, genetic variation, and risk of breast cancer |
| Q73798662 | Cigarette smoking increases risk for breast cancer in high-risk breast cancer families |
| Q94486442 | Combined associations of a polygenic risk score and classical risk factors with breast cancer risk |
| Q92299675 | Combined effect of volumetric breast density and body mass index on breast cancer risk |
| Q38613626 | Combining quantitative and qualitative breast density measures to assess breast cancer risk |
| Q47703662 | Common Genetic Variation and Breast Cancer Risk - Past, present, and future |
| Q35891162 | Common breast cancer susceptibility loci are associated with triple-negative breast cancer |
| Q36600605 | Common breast cancer susceptibility variants in LSP1 and RAD51L1 are associated with mammographic density measures that predict breast cancer risk |
| Q35794653 | Common germline polymorphisms associated with breast cancer-specific survival |
| Q34379032 | Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium |
| Q34253252 | Common occurrence of monoclonal B-cell lymphocytosis among members of high-risk CLL families |
| Q34792833 | Common variants in ZNF365 are associated with both mammographic density and breast cancer risk |
| Q36734692 | Common variants within 6p21.31 locus are associated with chronic lymphocytic leukaemia and, potentially, other non-Hodgkin lymphoma subtypes |
| Q36141922 | Common variation at 6p21.31 (BAK1) influences the risk of chronic lymphocytic leukemia |
| Q36950678 | Comparison of Clinical and Automated Breast Density Measurements: Implications for Risk Prediction and Supplemental Screening |
| Q30584519 | Comparison of percent density from raw and processed full-field digital mammography data |
| Q36031007 | Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study |
| Q47101456 | Corrigendum: Genome-wide association study identifies variants at 16p13 associated with survival in multiple myeloma patients |
| Q35562818 | Dense and nondense mammographic area and risk of breast cancer by age and tumor characteristics |
| Q91972629 | Detection and prevalence of monoclonal gammopathy of undetermined significance: a study utilizing mass spectrometry-based monoclonal immunoglobulin rapid accurate mass measurement |
| Q43646841 | Dietary folate intake, alcohol, and risk of breast cancer in a prospective study of postmenopausal women |
| Q57282816 | Differences in genomic abnormalities among African individuals with monoclonal gammopathies using calculated ancestry |
| Q92437923 | Discussions of Dense Breasts, Breast Cancer Risk, and Screening Choices in 2019 |
| Q36777222 | Disparities in the prevalence, pathogenesis and progression of monoclonal gammopathy of undetermined significance and multiple myeloma between blacks and whites |
| Q44797212 | Does folate intake decrease risk of postmenopausal breast cancer among women with a family history? |
| Q52675432 | Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics. |
| Q34381496 | Effect of aspirin and other NSAIDs on postmenopausal breast cancer incidence by hormone receptor status: results from a prospective cohort study |
| Q35940852 | Effect of menstrual cycle phase on background parenchymal uptake at molecular breast imaging |
| Q73822454 | Epidemiology and the Internet |
| Q42237545 | Erratum to: Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status |
| Q57202568 | Erratum: Corrigendum: Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q35105482 | Evaluating the influence of quality control decisions and software algorithms on SNP calling for the affymetrix 6.0 SNP array platform |
| Q57171683 | Evaluation of 2 breast cancer risk models in a benign breast disease cohort |
| Q94584133 | Evaluation of LIBRA Software for Fully Automated Mammographic Density Assessment in Breast Cancer Risk Prediction |
| Q36430014 | Evaluation of associations between common variation in mitotic regulatory pathways and risk of overall and high grade breast cancer |
| Q43421325 | Evaluation of potential sources of bias in a genetic epidemiologic study of breast cancer |
| Q36918235 | Evaluation of the Aromatase Inhibition Potential of Freeze-Dried Grape Powder |
| Q35653910 | Evaluation of variation in the phosphoinositide-3-kinase catalytic subunit alpha oncogene and breast cancer risk |
| Q73800167 | Evidence for a major gene influence on abdominal fat distribution: the Minnesota Breast Cancer Family Study |
| Q36720821 | Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors |
| Q37375286 | Evidence of systemic Th2-driven chronic inflammation in patients with metastatic melanoma |
| Q35064451 | Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation |
| Q37270445 | Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women |
| Q37594336 | FGF receptor genes and breast cancer susceptibility: results from the Breast Cancer Association Consortium |
| Q34146967 | Factors associated with breast cancer prevention communication between mothers and daughters |
| Q42686144 | Familial correlation of dietary intakes among postmenopausal women |
| Q36015178 | Familial monoclonal gammopathy of undetermined significance and multiple myeloma: epidemiology, risk factors, and biological characteristics |
| Q53415457 | Fifty-year follow-up of cancer incidence in a historical cohort of Minnesota breast cancer families. |
| Q37236216 | Fine scale mapping of the 17q22 breast cancer locus using dense SNPs, genotyped within the Collaborative Oncological Gene-Environment Study (COGs). |
| Q36111237 | Fine-Mapping of the 1p11.2 Breast Cancer Susceptibility Locus |
| Q35524465 | Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2. |
| Q61230414 | Fine-mapping of 150 breast cancer risk regions identifies 178 high confidence target genes |
| Q92480972 | Fine-mapping of 150 breast cancer risk regions identifies 191 likely target genes |
| Q34903062 | Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. |
| Q37367871 | Fine-scale mapping of the FGFR2 breast cancer risk locus: putative functional variants differentially bind FOXA1 and E2F1. |
| Q36124728 | Functional mechanisms underlying pleiotropic risk alleles at the 19p13.1 breast-ovarian cancer susceptibility locus |
| Q33589487 | Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes |
| Q43940206 | Genetic analysis of mammographic breast density in adult women: evidence of a gene effect |
| Q51981892 | Genetic anticipation and breast cancer: a prospective follow-up study. |
| Q29417068 | Genetic modifiers of menopausal hormone replacement therapy and breast cancer risk: a genome-wide interaction study |
| Q40969056 | Genetic services for familial cancer patients: a survey of National Cancer Institute cancer centers |
| Q36846498 | Genetic susceptibility to triple-negative breast cancer |
| Q33780771 | Genetic susceptibility variants for chronic lymphocytic leukemia |
| Q35179897 | Genetic variation at CYP3A is associated with age at menarche and breast cancer risk: a case-control study |
| Q34378972 | Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade |
| Q37131328 | Genetic variation in stromal proteins decorin and lumican with breast cancer: investigations in two case-control studies |
| Q33889494 | Genetic variation in the estrogen metabolic pathway and mammographic density as an intermediate phenotype of breast cancer |
| Q28388497 | Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types |
| Q35996692 | Genome-wide association analysis of more than 120,000 individuals identifies 15 new susceptibility loci for breast cancer |
| Q63681757 | Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer |
| Q24622610 | Genome-wide association studies identify four ER negative-specific breast cancer risk loci |
| Q29417100 | Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer |
| Q95329367 | Genome-wide association study identifies 32 novel breast cancer susceptibility loci from overall and subtype-specific analyses |
| Q28943377 | Genome-wide association study identifies a novel susceptibility locus at 6p21.3 among familial CLL |
| Q35061252 | Genome-wide association study identifies multiple loci associated with both mammographic density and breast cancer risk |
| Q28943339 | Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia |
| Q34033939 | Genome-wide association study of follicular lymphoma identifies a risk locus at 6p21.32. |
| Q64040390 | Genome-wide association study of germline variants and breast cancer-specific mortality |
| Q52646188 | Germline mutations in lysine specific demethylase 1 (LSD1/KDM1A) confer susceptibility to multiple myeloma. |
| Q36929353 | Healthy women's motivators and barriers to participation in a breast cancer cohort study: a qualitative study |
| Q36276540 | Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization |
| Q33330850 | Heterogeneity of breast cancer associations with five susceptibility loci by clinical and pathological characteristics |
| Q44431949 | High-folate diets and breast cancer survival in a prospective cohort study |
| Q55710658 | Higher alcohol intake may modify the association between mammographic density and breast cancer: an analysis of three case-control studies. |
| Q35624148 | Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues |
| Q35102646 | Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk |
| Q36062033 | Identification of a novel percent mammographic density locus at 12q24. |
| Q36859142 | Identification of four novel susceptibility loci for oestrogen receptor negative breast cancer |
| Q34038964 | Identification of new genetic susceptibility loci for breast cancer through consideration of gene-environment interactions |
| Q57170142 | Identification of nine new susceptibility loci for endometrial cancer |
| Q36014067 | Identification of novel genetic markers of breast cancer survival |
| Q46103372 | Identification of ten variants associated with risk of estrogen-receptor-negative breast cancer |
| Q100957803 | Impact of Personalized Genetic Breast Cancer Risk Estimation With Polygenic Risk Scores on Preventive Endocrine Therapy Intention and Uptake |
| Q64113541 | Impact of short-term low-dose tamoxifen on molecular breast imaging background parenchymal uptake: a pilot study |
| Q64360373 | Incidence of AL Amyloidosis in Olmsted County, Minnesota, 1990 through 2015 |
| Q34014125 | Incidence of chronic lymphocytic leukemia and high-count monoclonal B-cell lymphocytosis using the 2008 guidelines |
| Q114184688 | Incorporating progesterone receptor expression into the PREDICT breast prognostic model |
| Q36033380 | Increased prevalence of light chain monoclonal gammopathy of undetermined significance (LC-MGUS) in first-degree relatives of individuals with multiple myeloma |
| Q37275873 | Increased risk of monoclonal gammopathy in first-degree relatives of patients with multiple myeloma or monoclonal gammopathy of undetermined significance |
| Q34315843 | Independent association of lobular involution and mammographic breast density with breast cancer risk |
| Q34996647 | Inherited mutations in 17 breast cancer susceptibility genes among a large triple-negative breast cancer cohort unselected for family history of breast cancer |
| Q35104068 | Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer |
| Q61670387 | Interaction of adolescent anthropometric characteristics and family history on breast cancer risk in a Historical Cohort Study of 426 families (USA) |
| Q44177120 | Interaction of dietary folate intake, alcohol, and risk of hormone receptor-defined breast cancer in a prospective study of postmenopausal women |
| Q40155925 | Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes |
| Q51579135 | International Consortium on Mammographic Density: Methodology and population diversity captured across 22 countries. |
| Q43683815 | Investigation of an interaction of alcohol intake and family history on breast cancer risk in the Minnesota Breast Cancer Family Study |
| Q34898735 | Investigation of gene-environment interactions between 47 newly identified breast cancer susceptibility loci and environmental risk factors |
| Q64279327 | Joint association of mammographic density adjusted for age and body mass index and polygenic risk score with breast cancer risk |
| Q47190168 | Joint associations of a polygenic risk score and environmental risk factors for breast cancer in the Breast Cancer Association Consortium |
| Q29416989 | Large-scale genotyping identifies 41 new loci associated with breast cancer risk |
| Q33742726 | Linkage analysis of obesity phenotypes in pre- and post-menopausal women from a United States mid-western population |
| Q33994450 | Lobular involution: localized phenomenon or field effect? |
| Q92665826 | Longitudinal Changes in Volumetric Breast Density in Healthy Women across the Menopausal Transition |
| Q40440059 | Longitudinal Changes in Volumetric Breast Density with Tamoxifen and Aromatase Inhibitors |
| Q48577625 | Longitudinal trends in mammographic percent density and breast cancer risk. |
| Q61670391 | Lung Cancer Risk Reduction After Smoking Cessation: Observations From a Prospective Cohort of Women |
| Q36757554 | Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis |
| Q36785205 | Malignant melanoma in the 21st century, part 2: staging, prognosis, and treatment |
| Q36043843 | Mammographic breast density and breast cancer: evidence of a shared genetic basis |
| Q36265458 | Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort |
| Q35143969 | Mammographic breast density and subsequent risk of breast cancer in postmenopausal women according to tumor characteristics |
| Q48591452 | Mammographic breast density as a general marker of breast cancer risk. |
| Q36778183 | Mammographic breast density response to aromatase inhibition |
| Q33859833 | Mammographic density and ageing: A collaborative pooled analysis of cross-sectional data from 22 countries worldwide |
| Q35212997 | Mammographic density and breast cancer risk by family history in women of white and Asian ancestry |
| Q35663530 | Mammographic density and risk of breast cancer by adiposity: an analysis of four case-control studies |
| Q37690341 | Mammographic density and risk of breast cancer by age and tumor characteristics |
| Q37517477 | Mammographic density assessed on paired raw and processed digital images and on paired screen-film and digital images across three mammography systems |
| Q35076152 | Mammographic density does not differ between unaffected BRCA1/2 mutation carriers and women at low-to-average risk of breast cancer |
| Q39622978 | Mammographic density is the main correlate of tumors detected on ultrasound but not on mammography |
| Q36057738 | Mammographic density phenotypes and risk of breast cancer: a meta-analysis |
| Q36465317 | Mammographic density, breast cancer risk and risk prediction |
| Q37476623 | Mammographic texture and risk of breast cancer by tumor type and estrogen receptor status |
| Q33739170 | Mammographic texture resemblance generalizes as an independent risk factor for breast cancer |
| Q36680976 | Mapping of the IRF8 gene identifies a 3'UTR variant associated with risk of chronic lymphocytic leukemia but not other common non-Hodgkin lymphoma subtypes |
| Q114182490 | Mendelian randomisation study of smoking exposure in relation to breast cancer risk |
| Q57268430 | Menstrual and reproductive factors and risk of non-Hodgkin lymphoma: the Iowa women's health study (United States) |
| Q36675182 | Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia |
| Q37414693 | Methods for assessing and representing mammographic density: an analysis of 4 case-control studies |
| Q34497352 | MicroRNA related polymorphisms and breast cancer risk |
| Q52574603 | Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia. |
| Q35144259 | Model for individualized prediction of breast cancer risk after a benign breast biopsy |
| Q58546150 | Molecular mechanisms linking high body mass index to breast cancer etiology in post-menopausal breast tumor and tumor-adjacent tissues |
| Q36897003 | Multiple independent variants at the TERT locus are associated with telomere length and risks of breast and ovarian cancer |
| Q38629398 | NanoString-based breast cancer risk prediction for women with sclerosing adenosis |
| Q36610181 | Natural history of age-related lobular involution and impact on breast cancer risk |
| Q61670380 | No Association Between 25-Hydroxyvitamin D and Mammographic Density |
| Q30374367 | No clinical utility of KRAS variant rs61764370 for ovarian or breast cancer. |
| Q36393107 | No evidence for association of inherited variation in genes involved in mitosis and percent mammographic density |
| Q37079859 | No evidence that protein truncating variants in BRIP1 are associated with breast cancer risk: implications for gene panel testing |
| Q35752042 | Novel Associations between Common Breast Cancer Susceptibility Variants and Risk-Predicting Mammographic Density Measures |
| Q37474380 | Novel breast tissue feature strongly associated with risk of breast cancer |
| Q28584533 | PALB2, CHEK2 and ATM rare variants and cancer risk: data from COGS |
| Q83087121 | Palpable presentation of breast cancer persists in the era of screening mammography |
| Q36727026 | Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women |
| Q62583133 | Polygenic Risk Scores for Prediction of Breast Cancer and Breast Cancer Subtypes |
| Q36066735 | Polymorphisms in a Putative Enhancer at the 10q21.2 Breast Cancer Risk Locus Regulate NRBF2 Expression |
| Q33921008 | Polymorphisms in stromal genes and susceptibility to serous epithelial ovarian cancer: a report from the Ovarian Cancer Association Consortium |
| Q36295033 | Postmenopausal mammographic breast density and subsequent breast cancer risk according to selected tissue markers |
| Q36583004 | Prediction of breast cancer risk based on profiling with common genetic variants |
| Q73098352 | Preliminary sibpair linkage analysis of percent mammographic density |
| Q46533339 | Prenatal and perinatal correlates of adult mammographic breast density |
| Q81497735 | Prepregnancy exposure to cigarette smoking and subsequent risk of postmenopausal breast cancer |
| Q28390064 | Prevention of breast cancer in postmenopausal women: approaches to estimating and reducing risk |
| Q46093001 | Preventive health behaviors and familial breast cancer |
| Q55508030 | Publisher Correction: Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. |
| Q90242034 | Publisher Correction: Shared heritability and functional enrichment across six solid cancers |
| Q55282717 | Quantitative background parenchymal uptake on molecular breast imaging and breast cancer risk: a case-control study. |
| Q33600826 | Racial differences in primary cytogenetic abnormalities in multiple myeloma: a multi-center study |
| Q114182625 | Rare germline copy number variants (CNVs) and breast cancer risk |
| Q61670381 | Recreational Physical Activity and Risk of Postmenopausal Breast Cancer Based on Hormone Receptor Status |
| Q36955678 | Relative weight at age 12 and risk of postmenopausal breast cancer |
| Q73062975 | Risk of breast cancer with oral contraceptive use in women with a family history of breast cancer |
| Q71731993 | Segregation analysis of breast cancer: a comparison of type-dependent age-at-onset versus type-dependent susceptibility models |
| Q61118451 | Shared heritability and functional enrichment across six solid cancers |
| Q64004349 | Shared heritability and functional enrichment across six solid cancers |
| Q104073042 | Simplified breast risk tool integrating questionnaire risk factors, mammographic density, and polygenic risk score: development and validation |
| Q36999599 | Single-nucleotide polymorphism rs1052501 associated with monoclonal gammopathy of undetermined significance and multiple myeloma |
| Q49789127 | Stroma modifies relationships between risk factor exposure and age-related epithelial involution in benign breast. |
| Q51739138 | Strong evidence of a genetic determinant for mammographic density, a major risk factor for breast cancer. |
| Q37004883 | Susceptibility genes and B-chronic lymphocytic leukaemia |
| Q37173802 | Texture features from mammographic images and risk of breast cancer |
| Q92608385 | The Association of Modifiable Breast Cancer Risk Factors and Somatic Genomic Alterations in Breast Tumors: The Cancer Genome Atlas Network |
| Q90371796 | The CCND1 c.870G risk allele is enriched in individuals of African ancestry with plasma cell dyscrasias |
| Q91178389 | The FANCM:p.Arg658* truncating variant is associated with risk of triple-negative breast cancer |
| Q57025274 | The National Cancer Institute Cohort Consortium: an international pooling collaboration of 58 cohorts from 20 countries |
| Q35685546 | The association of copy number variation and percent mammographic density |
| Q52642368 | The association of mammographic density with risk of contralateral breast cancer and change in density with treatment in the WECARE study. |
| Q36137764 | The contributions of breast density and common genetic variation to breast cancer risk |
| Q36981617 | The influence of mammogram acquisition on the mammographic density and breast cancer association in the Mayo Mammography Health Study cohort |
| Q36999585 | Tissue composition of mammographically dense and non-dense breast tissue |
| Q40066307 | Tissue-based associations of mammographic breast density with breast stem cell markers |
| Q89961489 | Transcriptome-wide association study of breast cancer risk by estrogen-receptor status |
| Q91833083 | Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B-cell lymphocytosis beyond the CLL international prognostic index |
| Q92994868 | Two truncating variants in FANCC and breast cancer risk |
| Q28093812 | Unsupervised Deep Learning Applied to Breast Density Segmentation and Mammographic Risk Scoring |
| Q36255311 | Using Breast Cancer Risk Associated Polymorphisms to Identify Women for Breast Cancer Chemoprevention |
| Q35644558 | Whole Genome Sequence of Multiple Myeloma-Prone C57BL/KaLwRij Mouse Strain Suggests the Origin of Disease Involves Multiple Cell Types |
| Q37414133 | rs2735383, located at a microRNA binding site in the 3'UTR of NBS1, is not associated with breast cancer risk |
Search more.